Albemarle Corporation
ALB
$143.25
+6.75%
Albemarle Corporation is a global specialty chemicals company and one of the world's largest producers of lithium, a key component in batteries for electric vehicles and energy storage. It also leads in bromine and other specialty chemicals, serving diverse industries. As a fully integrated lithium producer with operations in Chile, the US, Australia, and China, Albemarle holds a dominant position in the lithium supply chain. The current investor narrative centers on the cyclical recovery of lithium prices, the company's cost-cutting measures, and its strategic positioning to benefit from the accelerating EV adoption, despite recent earnings volatility and a significant stock price drawdown.…
ALB
Albemarle Corporation
$143.25
Related headlines
Investment Opinion: Should I buy ALB Today?
Based on the analysis, ALB is rated a Buy. The thesis is that Albemarle is a leading lithium producer poised to benefit from the EV revolution, with a strong revenue recovery and attractive valuation. The analyst consensus is Buy with an average target of $173.56, implying 27.5% upside from the current price of $136.15.
Sign up to view all
ALB 12-Month Price Forecast
The AI model assesses ALB as bullish, given the strong revenue acceleration, attractive valuation, and positive analyst sentiment. The main uncertainty is the sustainability of lithium prices, which could impact earnings. If lithium prices hold above $18,000/ton, the stock is likely to re-rate higher. However, a sharp decline in lithium prices would invalidate the bullish thesis. The model would upgrade to high confidence if Q2 2026 earnings confirm the recovery, and downgrade to neutral if lithium prices fall below $15,000/ton.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Albemarle Corporation's 12-month outlook, with a consensus price target around $173.56 and implied upside of +21.2% versus the current price.
Average Target
$173.56
0 analysts
Implied Upside
+21.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$83 - $225
Analyst target range
The price target range spans from a low of $83.28 to a high of $225.00, reflecting a wide dispersion of views on Albemarle's future. The high target of $225 assumes a full recovery in lithium prices and successful execution of cost-saving initiatives, potentially leading to record earnings. The low target of $83.28 implies a scenario where lithium prices remain depressed or the company faces operational challenges, resulting in sustained losses. The wide spread between the low and high targets (a 170% difference) indicates significant uncertainty about the timing and magnitude of the lithium cycle recovery. However, the recent upgrade from Citigroup and the overall bullish consensus suggest that analysts are becoming more optimistic about the stock's prospects, which could lead to further upside if the company delivers on its earnings estimates.
Bulls vs Bears: ALB Investment Factors
Albemarle presents a compelling turnaround story with strong revenue growth, a return to profitability, and an attractive forward valuation. The bull case is supported by a 32.7% revenue surge, a forward PE of 11.8x, and a consensus Buy rating with 27.5% upside. However, the bear case highlights the cyclicality of lithium prices, high earnings volatility, and a negative trailing net margin. The most critical tension is whether the lithium price recovery is sustainable; if prices hold, the stock is undervalued, but a downturn could lead to significant downside. Currently, the evidence slightly favors the bulls given the strong Q1 performance and analyst optimism, but the risk of a lithium price correction remains the key swing factor.
Bullish
- Strong Revenue Recovery: Q1 2026 revenue surged 32.7% YoY to $1.43B, marking a sharp rebound from the $1.08B trough in Q1 2025. This acceleration is driven by higher lithium prices and volumes, indicating the lithium market is recovering.
- Return to Profitability: Q1 2026 EPS of $2.35 and net income of $319M contrast sharply with the prior year's losses, demonstrating operational leverage. The gross margin expanded to 35.1% from 14.3% a year ago, reflecting cost discipline and pricing power.
- Attractive Forward Valuation: With a forward PE of 11.8x and PEG of 0.51, the stock is priced well below the specialty chemicals industry average. Analysts expect EPS of $13.85 next year, implying a significant earnings recovery that is not yet fully reflected in the price.
- Analyst Consensus Buy: 20 analysts rate ALB a Buy with an average target of $173.56, representing 27.5% upside from the current price of $136.15. Recent upgrades, including from Citigroup, suggest growing optimism on the lithium cycle.
Bearish
- High Earnings Volatility: Trailing twelve-month EPS is -$0.03, and the company has swung between large losses (e.g., -$3.87 in Q4 2025) and profits (Q1 2026). This volatility makes valuation and earnings visibility challenging.
- Lithium Price Cyclicality: The stock's performance is highly tied to lithium prices, which have been volatile. The 52-week range of $71.25 to $221.00 highlights the extreme swings, and a downturn in lithium prices could quickly erode earnings.
- Negative Net Margin: Despite the recent recovery, the net margin over the trailing twelve months is -9.9%, indicating that the company is not yet consistently profitable. This raises concerns about the sustainability of the recovery.
- High Debt Levels: Debt-to-equity ratio of 0.35 and interest expenses of $33M in Q1 2026 add financial risk, especially if lithium prices fall and cash flows weaken. The company's EV/EBITDA of 32.7x is elevated, suggesting high leverage relative to earnings.
ALB Technical Analysis
Albemarle's stock has experienced a volatile but ultimately strong uptrend over the past year, with a 1-year price change of +67.2%, significantly outperforming the S&P 500's +20.4% gain. However, the stock is currently trading at $136.15, which is only 43% of its 52-week range (between $71.25 low and $221.00 high), indicating it has pulled back sharply from its highs. This positioning suggests the stock is in a corrective phase after a strong rally, potentially offering a value opportunity if the longer-term uptrend resumes, but also carrying the risk of further downside if the correction deepens.
Beta
1.32
1.32x market volatility
Max Drawdown
-47.5%
Largest decline past year
52-Week Range
$71-$221
Price range past year
Annual Return
+81.5%
Cumulative gain past year
| Period | ALB Return | S&P 500 |
|---|---|---|
| 1m | +22.0% | +2.5% |
| 3m | -16.5% | +2.7% |
| 6m | -14.9% | +11.1% |
| 1y | +81.5% | +20.5% |
| ytd | -0.5% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALB Fundamental Analysis
Albemarle's revenue has shown a strong recovery, with Q1 2026 revenue of $1.43 billion, up 32.7% year-over-year, marking a significant acceleration from the prior year's levels. The company's revenue trajectory has been volatile, with a trough in Q1 2025 at $1.08 billion, but has since rebounded strongly, driven by higher lithium prices and volumes. The Energy Storage segment, which includes lithium, generated $891 million in revenue, representing 62% of total revenue, and is the primary growth driver, while Specialties contributed $358 million. This growth is a positive sign for the investment case, indicating that the lithium market is recovering and Albemarle is capturing the upside.
Quarterly Revenue
$1.4B
2026-03
Revenue YoY Growth
+32.7%
YoY Comparison
Gross Margin
35.1%
Latest Quarter
Free Cash Flow
$577275000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALB Overvalued?
Given that Albemarle's trailing twelve-month net income is negative (EPS of -$0.03), the price-to-sales (PS) ratio is the most appropriate valuation metric, as it focuses on revenue generation rather than profitability. The current PS ratio is 3.24x, which is lower than the industry average of 4.5x (based on specialty chemicals peers), suggesting the stock is trading at a discount to its sector. The forward PE ratio of 11.8x implies that the market expects a significant earnings recovery, which is supported by analyst estimates of EPS of $13.85 for the next fiscal year. This gap between trailing losses and forward profitability indicates that investors are pricing in a strong cyclical rebound, which could either be justified by the lithium upcycle or lead to disappointment if the recovery stalls.
PE
-24.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 5x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
32.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. Albemarle's trailing twelve-month net income is negative, with an EPS of -$0.03, and the net margin is -9.9%, indicating that the company is not consistently profitable. The debt-to-equity ratio of 0.35 and interest expenses of $33M in Q1 2026 add financial leverage, which could strain cash flows if lithium prices decline. Revenue concentration in the Energy Storage segment (62% of total revenue) exposes the company to lithium price volatility, as seen in the wide swings in quarterly earnings. The gross margin improved to 35.1% in Q1 2026, but this is still below historical highs, and any operational hiccup could reverse the progress.